Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: South Med J. 2023 Jun;116(6):455–463. doi: 10.14423/SMJ.0000000000001564

Table 3.

Proportion of first-time PrEP users with any STI test, a syphilis test, or a chlamydia and/or gonorrhea test within first 12 mo (states D, E, F)

State D State E State F

Characteristic Any STI, % Syphilis, % Chlamydia or gonorrhea, % Any STI, % Syphilis, % Chlamydia or gonorrhea, % Any STI, % Syphilis, % Chlamydia or gonorrhea, %
Age group, y
16–19 58.9 53.6 50.0 54.5 45.5 54.5 37.5 25.0 37.5
20–24 54.2 45.8 45.8 57.1 50.0 57.1
25–29 50.0 45.5 27.3 41.2 29.4 41.2 75.0 50.0 66.7
30–34 76.2 66.7 61.9
35–39 53.3 26.7 53.3 66.7 50.0 58.3
40–64 57.1 45.2 45.2 43.8 37.5 31.3 59.1 54.5 50.0
Race/ethnicity
Non-Hispanic White 50.0 41.7 38.9 53.8 38.5 53.8 54.5 45.5 54.5
Non-Hispanic Black 62.7 54.2 49.4 50.0 40.0 42.5 69.6 47.8 65.2
Hispanic
Other 65.0 50.0 60.0 45.5 42.4 39.4
Sex
Female 61.5 51.3 47.9 57.4 44.4 51.9 71.4 57.1 65.7
Male 52.4 44.4 46.0 38.1 33.3 38.1 41.9 34.9 39.5
Eligibility group
Children, 16–19 y 58.9 53.6 50.0 54.5 45.5 54.5 37.5 25.0 37.5
Disabled adults 66.7 52.1 62.5 52.4 38.1 42.9 65.6 56.3 62.5
AMedicaid expansion adults
Nondisabled, nonexpansion adults 54.3 45.7 37.1 51.2 41.9 48.8 53.3 43.3 46.7
Living area
Urban 60.4 50.7 47.9 49.1 38.6 47.4 58.5 49.2 53.8
Rural 50.0 41.7 44.4 64.7 52.9 52.9
Total 58.3 48.9 47.2 52.0 41.3 48.0 55.0 45.0 51.0

PrEP, preexposure prophylaxis; STI, sexually transmitted infection.

A

In Table 3, row Medicaid expansion adults, should the entire row be “—” (there were no data and no — in the State E section as originally received)?